摘要
目的:观察中西医结合治疗慢性乙型肝炎肝纤维化的疗效。方法:慢性乙型肝炎肝纤维化病人75例,随机分为治疗组和对照组,对照组给予西药常规保肝治疗,治疗组在此基础上加用大黄虫丸治疗。2个疗程后对两组患者治疗前后的血清肝纤维化指标(HA、LN、Ⅳ-C、PCⅢ、TGF-β1)进行检测。结果:治疗组与对照组均可降低血清肝纤维化指标,但治疗组治疗后各种指标降低的幅度明显优于对照组(P<0.01)。结论:中西医结合治疗慢性乙型肝炎肝纤维化的疗效更好。
Objective: To observe the clinical effect on the treatment of the Hepatic Fibrosis with Chronic Hepatic B by therapy of integrated Chinese and western meicine. Methods: 75 cases were divided into two groups randomly. Western normal medicines were used in both groups. Dahuangzhechong Pill was added to used in therapeutic group, one course was 3 monthes and 2 courses were used. the indexes Hepatic Fibrosis ( HA, LN,ⅣC, PCⅢ) were detemined in pretherapy and post-treatment, respectively. Results: Serum index of Hepatic Fibrosis were decreased in both groups. But the therapeu groups are superior to the control groups (P〈0.01). Conclusion: The results show that there are good effects on treating Hepatic Fibrosis by integrated Chinese and western meicine.
出处
《世界中西医结合杂志》
2007年第2期97-98,共2页
World Journal of Integrated Traditional and Western Medicine
关键词
慢性乙型肝炎
肝纤维化
中西医结合
大黄座虫丸
Chronic Hepatic B
Hepatic Fibrosis
therapy of integrated Chinese and western medicine
Dahuangzhechong Pill